Emphysema Treatment Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Emphysema Treatment Market Expected To Reach $7.91 Billion By 2030 At 8.1% CAGR
The emphysema treatment market has experienced robust expansion in recent years. By 2025, its size is estimated at $5.4 billion, with projections reaching $5.8 billion in 2026, reflecting a compound annual growth rate of 7.4%. This historical growth has been driven by factors such as a rise in chronic obstructive pulmonary disease cases, a growing number of smokers, limited public awareness regarding early diagnosis, widespread use of conventional inhalation therapies, and enhanced hospital infrastructure in developing nations.
The emphysema treatment market is anticipated to experience significant expansion in the foreseeable future. It is projected to reach $7.91 billion by 2030, with a compound annual growth rate (CAGR) of 8.1%. This forecast growth is driven by progress in gene therapy, greater uptake of digital health solutions, expansion of home-based healthcare, creation of portable oxygen devices, and a rising preference for less invasive surgical interventions. Key developments shaping the coming period include tailored treatment approaches, solutions for care delivered at home, non-invasive therapeutic options, remote monitoring via telehealth, and sophisticated pulmonary rehabilitation initiatives.
Download A Free Sample Report For Comprehensive Market Insights:
Emphysema Treatment Market Demand Drivers Creating New Revenue Opportunities
The anticipated increase in chronic obstructive pulmonary disease (COPD) cases is set to accelerate the growth of the emphysema treatment market in the coming period. COPD encompasses a group of lung conditions, such as emphysema and chronic bronchitis, that result in obstructed airflow and breathing challenges. Emphysema treatments play a critical role in slowing the progression of COPD by managing symptoms, improving lung function, and delaying the deterioration of the disease. A research study published in December 2023 by JAMA Network Open, a medical journal under the American Medical Association, indicated that the worldwide incidence of COPD is projected to reach nearly 600 million cases by 2050, reflecting a 23% rise in prevalence. Consequently, the growing number of COPD cases is a key factor driving the emphysema treatment market forward.
Emphysema Treatment Market Segment Analysis: What Are The Major Market Categories?
The emphysema treatment market covered in this report is segmented –
1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users
Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
4) By Leukotriene Modifiers: Montelukast, Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care
Emphysema Treatment Market Trends Driving Strategic Industry Expansion
Major players in the emphysema market are focusing on the development of cutting-edge products, such as inhalation aerosols, to secure a competitive advantage. These aerosols are pharmaceutical preparations released as a fine mist or spray, containing liquid medication suspended in a propellant or a blend of propellants. A notable example occurred in July 2023, when Viatris Inc., a pharmaceutical company based in the United States, partnered with Kindeva Drug Delivery L.P., a US-based contract development and manufacturing organization (CDMO), to introduce Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. This product became the first FDA-approved generic version of AstraZeneca’s Symbicort, intended for patients dealing with asthma, chronic obstructive pulmonary disease (COPD), and emphysema. Offered in 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths, this drug-device combination represents a significant milestone in delivering affordable and accessible treatment options for those with respiratory conditions. Breyna is specifically formulated to manage airflow obstruction maintenance, decrease exacerbations in COPD patients, and control asthma symptoms in individuals aged six and older, including those affected by emphysema.
Emphysema Treatment Market Leading Companies Driving Competitive Growth
Major companies operating in the emphysema treatment market are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc.
Access The Complete Emphysema Treatment Market Report:
Emphysema Treatment Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the emphysema treatment market in 2025. The regions covered in the emphysema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
